Deerfield Management’s Starling Oncology Warrant STLNW Stock Holding History
Bought
Maintained
Sold
Other funds holding STLNW
OMC
LP
WAM
DKCM
AGM
TCM
Deerfield Management's STLNW Position: Q2 2026 in Review
Deerfield Management held its Starling Oncology Warrant (STLNW) position steady in Q2 2026 at 1,250,000 shares worth $51K. The position accounts for ﹤0.01% of the portfolio, ranked #80.
Deerfield Management first reported a position in STLNW in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.16M in Q2 2021. 12 funds tracked by Wall St. Rank hold STLNW as of Q2 2026.
- Deerfield Management held 1,250,000 shares of Starling Oncology Warrant worth $51K as of Q2 2026.
- Deerfield Management left its Starling Oncology Warrant share count unchanged in Q2 2026.
- Starling Oncology Warrant made up ﹤0.01% of Deerfield Management's portfolio in Q2 2026, its #80 holding.
- Deerfield Management first reported a position in Starling Oncology Warrant in Q1 2021 and has held it in 22 quarters since.
- Deerfield Management's Starling Oncology Warrant position peaked at $2.16M in Q2 2021.
- 12 funds tracked by Wall St. Rank held Starling Oncology Warrant as of Q2 2026.
Based on Deerfield Management's 13F filing for Q2 2026, filed 14 Aug 2026.